Eindhoven, Netherlands

Sieglinde Neerken

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 7.1

ph-index = 1

Forward Citations = 15(Granted Patents)


Location History:

  • AE Eindhoven, NL (2019)
  • Eindhoven, NL (2014 - 2021)

Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Sieglinde Neerken: Innovator in Selective Cell Lysis and Digital Pathology

Introduction:

Sieglinde Neerken is a renowned innovator and inventor based in Eindhoven, Netherlands. With a passion for transforming healthcare technologies, Neerken has contributed significantly to the fields of selective lysis of cells and information transformation in digital pathology. Through her expertise and dedication, Neerken has earned recognition for her contributions to advancements in medical diagnostics and pathology.

Latest Patents:

Neerken's latest patents demonstrate her expertise in two distinct areas: selective lysis of cells and information transformation in digital pathology.

1. Selective lysis of cells:

Neerken's patent on "Selective lysis of cells" focuses on the methods and devices for detecting micro-organisms in mammalian blood samples. Her innovative approach involves incubating the sample in a non-ionic detergent under alkaline conditions, thus achieving a selective lysis. This breakthrough technique enhances the accuracy and efficiency of detecting micro-organisms in blood samples, enabling improved diagnostic capabilities.

2. Information transformation in digital pathology:

Neerken's second patent in "Information transformation in digital pathology" revolutionizes the field of pathology by streamlining the transfer of annotations from reference slides to sample slides. Through image recognition techniques, annotations made on a reference slide are accurately copied onto the corresponding sample slide. This innovation significantly improves the efficiency of pathology analysis by automating the process of transferring annotations and reducing manual efforts.

Career Highlights:

Neerken has achieved remarkable accomplishments throughout her career. Notably, she has worked with prestigious companies such as Philips Corporation and Biocartis. Neerken's employment at Koninklijke Philips Corporation N.V., popularly known as Philips, provided her with an exceptional platform to contribute to cutting-edge medical technologies and innovations. Her work with Biocartis, an innovative molecular diagnostics company, further demonstrated her commitment to driving advancements in healthcare.

Collaborations:

Throughout her career, Neerken has collaborated with talented professionals to further her groundbreaking research. Notable collaborators include Paul Arnold Van De Wiel and Roel Penterman, among others. Their combined expertise and shared vision have led to successful advancements in the fields of selective cell lysis and information transformation in digital pathology. Such collaborations exemplify Neerken's collaborative spirit and commitment to cross-disciplinary innovation.

Conclusion:

Sieglinde Neerken's contributions as an inventor and innovator in the fields of selective lysis of cells and information transformation in digital pathology have significantly impacted medical diagnostics and pathology. Her novel approaches and patents showcase her passion for improving healthcare technologies, enabling enhanced diagnostic capabilities and streamlining pathology analysis. Neerken continues to drive transformative innovations, contributing to the future of medical diagnostics and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…